2 Sun Pharma US Units To Pay $85M In Generic Drugs MDL
By Hailey Konnath · November 5, 2021, 10:04 PM EDT
Two U.S. subsidiaries of Indian drugmaker Sun Pharma have agreed to shell out a combined $85 million to a proposed class of direct purchaser plaintiffs in sweeping multidistrict litigation over alleged...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login